These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15237009)

  • 1. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
    Jain T; Soules MR; Collins JA
    Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
    Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
    Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
    Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
    Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
    Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
    Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercycle variability of ovarian reserve tests: results of a prospective randomized study.
    Kwee J; Schats R; McDonnell J; Lambalk CB; Schoemaker J
    Hum Reprod; 2004 Mar; 19(3):590-5. PubMed ID: 14998957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clomiphene citrate challenge test (CCCT) in women with elevated basal FSH: biological significance and predictive value.
    Ragni G; Chiaffarino F; Scarduelli C; Bonetti S; Nicolosi AE; Arnoldi M; Somigliana E
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):44-8. PubMed ID: 18676080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone.
    Scott RT; Elkind-Hirsch KE; Styne-Gross A; Miller KA; Frattarelli JL
    Fertil Steril; 2008 Apr; 89(4):868-78. PubMed ID: 17603049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H; Thum MY
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review.
    Hendriks DJ; Mol BW; Bancsi LF; te Velde ER; Broekmans FJ
    Fertil Steril; 2006 Oct; 86(4):807-18. PubMed ID: 16962116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women.
    Haadsma ML; Groen H; Fidler V; Bukman A; Roeloffzen EM; Groenewoud ER; Broekmans FJ; Heineman MJ; Hoek A
    Hum Reprod; 2008 Aug; 23(8):1800-7. PubMed ID: 18567901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and treatment of low responders.
    Scott RT
    Semin Reprod Endocrinol; 1996 Nov; 14(4):317-37. PubMed ID: 8988527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population.
    Scott RT; Leonardi MR; Hofmann GE; Illions EH; Neal GS; Navot D
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):539-44. PubMed ID: 8377979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve.
    Hofmann GE; Khoury J; Michener C
    Fertil Steril; 2002 Jul; 78(1):47-50. PubMed ID: 12095489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone.
    Ozkaya O; Kaya H; Sezik M; Akyürek C; Ozbaşar D
    Int J Fertil Womens Med; 2004; 49(2):83-7. PubMed ID: 15188834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.